By Brazil Stock Guide – The Brazilian development bank BNDES has approved a R$107.6 million financing package for EMS, Brazil’s largest pharmaceutical group, to expand its Research, Development and Innovation Center in Hortolândia, São Paulo. The approval, disclosed on Monday by Broadcast, was granted under the BNDES Mais Inovação program.
The investment will fund structural upgrades, the construction of new facilities and the purchase of advanced laboratory equipment — including dissolvers, chromatographs, viscometers, centrifuges, spectrophotometers and diffractometers. EMS says the expansion will increase the center’s total area by about 70%, doubling its ability to develop new R&D projects.
In a statement, BNDES President Aloizio Mercadante said the financing reinforces the domestic pharmaceutical industry’s innovation capacity. “The expansion of infrastructure dedicated to the development of new drugs has the potential to reduce vulnerabilities in the public health system and broaden access to healthcare,” he said.
BNDES also noted the project will support EMS’s international growth plans, with a new R&D unit designed specifically for external markets, focusing on Europe and North America.
Leave a Reply